Back Refine search Reset
Please choose a search criteria from below
Filters Clear all
Specialties
Treatments

100+ results found in London, UK

Sort by:
Showing 81 - 90 of 100+ results
Oncology
18 years of experience
Breast Cancer, Clinical Oncology, Medical Oncology

Dr Sheeba Irshad is a Breast Cancer Medical Oncologist at Guy’s & St Thomas’ NHS Trust and a Senior Clinical Lecturer at King’s College London. She is also a Cancer Research UK Clinician Scientist.

Following her return as a visiting scientist at The Sidney Kimmel Comprehensive Cancer Center at John’s Hopkins University, Baltimore; Dr Irshad was appointed as a Clinical Deputy Head of King’s College London Breast Cancer Now Research Unit Programme in 2018.

She specialises in researching hard to treat breast cancers, such as those that are resistant to chemotherapy. Her research is focused on understanding the tumour-immune cell cross talk in chemotherapy resistant cancers with particular emphasis on understanding mechanisms that underpin how cells from the immune system move within tumours. The goal is to find effective immunotherapy treatments for patients.

She is also the translational lead and coordinating investigator for a clinical trial platform to explore the potential interactions between DNA damage response inhibitors and immunotherapy in high-risk Triple Negative Breast Cancers.


Diseases, Medical Tests and Treatments
  • Oncology
  • Cancer Research
  • Breast Cancer
  • Immunotherapies
Read more
Oncology
37 years of experience
Clinical Oncology

Professor Ros Eeles is Professor of Oncogenetics at The Institute of Cancer Research, University of London UK. She trained at The University of Cambridge, UK and St Thomas' Hospital, London. She is a Fellow of the Royal College of Physicians and Royal College of Radiologists (Clinical Oncology Faculty), London UK. She is accredited in Clinical Oncology and has extensive sub-specialist experience in Cancer Genetics.

Professor Eeles' oncological practice is in radiotherapy and chemotherapy for Uro-Oncology. Her cancer genetics practice involves cancer risk assessment, screening advice and management of increased cancer risk in adults for any cancer site. She is also an expert in how the new cancer genetics impacts on treatment decisions. She has edited a specialist textbook on Cancer Prevention and Screening which won the BMA Chairman's award in 2019. She is an author of over 500 original research papers. She has an international standing in Cancer Genetic Clinical Management and research, particularly management of individuals with mutations in the breast/ovarian/prostate cancer predisposition genes, BRCA1, BRCA2 and other genes and genetic predisposition to prostate cancer. She has been on several genetics advisory committees and edited the special edition of Familial Cancer: Cancer Genetics: New Ways of Working which reported on models of delivery of cancer genetics services.

She is a member of the learned societies: ESTRO, ESMO, ASHG, AACR, BAUS, ESHG, ASCO, BSGM and CGG UK

Her outside interests are Opera and Art.


Diseases, Medical Tests and Treatments
  • Clinical Genetics wrt cancer in adults
  • Cancer genetics
  • Prostate Genetics
  • Clinical genetics wrt cancer genetics in adults
  • Cancer genetics
  • Medical genetics
  • Prostate Genetics
Read more
Oncology
33 years of experience
Cancer of the Head, Neck, Mouth, and Tongue, Clinical Oncology, Nasal and Sinus Cancer + 2more

Dr Goodchild is a consultant clinical oncologist with 30 years of experience in treating head, neck, and thyroid cancer. She is the Co-Chair of the London Clinic Thyroid MDT. Her main areas of interest are head and neck cancer, thyroid cancer, and benign thyroid disease. Some of the common treatments she offers are delivery of concurrent chemoradiation; radical radiotherapy (IMRT); palliative chemotherapy or radiotherapy; targeted drug treatments and immunotherapy.

Read more
Oncology
27 years of experience
Clinical Oncology, Head and Neck Cancers, Lung Cancer

Dr Ruheena Mendes is a Consultant Clinical Oncologist who specialises in Head and neck cancer, lung cancer, small cell lung cancer, Non-small cell lung and Other types of lung cancer.


Diseases, Medical Tests and Treatments
  • Radiotherapy
  • Head and neck cancer
  • Lung cancer
  • Small cell lung cancer
  • Non-small cell lung
  • Other types of lung cancer
Read more
Oncology
28 years of experience
Medical Oncology
Oncology
30 years of experience
Clinical Oncology, Head and Neck Cancers, Lung Cancer

 Dr Dawn Carnell is a Consultant Clinical Oncologist, based at University College Hospital, London. She is UCH's Clinical Lead for lung cancer and Lead Consultant Clinical Oncologist for head and neck cancer.

Dr Carnell trained at the Royal Free Hospital in London and after completing her MRCP, she undertook oncology training at the Royal Marsden and Middlesex/University College Hospitals. Dr Carnell’s formal research was at Mount Vernon Hospital, where she looked at hypoxia (low oxygen levels) in cancer and how this could be mapped histologically and using Blood Oxygen Level Dependent Magnetic Resonance Imaging. The future role for this would be to direct radiation boosts to radio-resistant hypoxic regions in cancer and to identify hypoxic tumours for specific treatments aimed at hypoxic cancer cells, resulting in improved cure rates. She is also the principal investigator for the PET-NECK trial looking at the role of early PET scanning to direct post radiation surgery and is involved in other research on the utility of respiratory gating in lung cancer.

Other clinical interests include general ENT and Maxillofacial and in particular sinus cancer and therapies such as Intensity Modulated Radiotherapy, as well as concurrent chemoradiation protocols and the use of molecular targeted treatments. She also has a particular interest in sinus tumours.

Dr Carnell also teaches and is one of the Lead Clinicians for Medical Student Teaching (the Head and Neck/Lung and CNS group)and contributes regularly to registrar teaching within oncology and ENT.

 

 

 

 

 


Diseases, Medical Tests and Treatments
  • Radiotherapy
  • Chemotherapy
  • Head & Neck Cancers
  • Lung Cancer
  • Nasal & Sinus Cancer
Read more
Oncology
26 years of experience
Gynaecological Oncology, Medical Oncology, Ovarian Cancer

Dr Shibani Nicum is a Consultant Medical Oncologist, specialising in ovarian and other gynaecological cancers and is based at the Oxford Cancer Centre, in addition to seeing private patients at a variety of hospitals, including in London. Dr Nicum is a graduate of Birmingham Medical School and then completed specialist oncology training at the Royal Marsden Hospital in London, before taking up her role in Oxford in 2009. She is the Lead Clinician for the Gynaecology Unit, the Oxford Multidisciplinary Team and the Thames Valley Gynaecology Alliance Group.

She is particularly interested in BRCA mutated cancers and the development of new therapies for individualised care. Dr Nicum was awarded a national grant from Cancer Research UK to undertake laboratory-based research and also awarded a DPhil from the University of Oxford in 2007. She contributes regularly to peer review journals and speaks at conferences. She is also the Gynaecology Research Lead and has responsibility for translating laboratory advances into benefit for patients. This incudes being Chief Investigator for the CRUK OCTOVA trial, the 6MP BRCA trial and the upcoming ICON9 trial in addition to being principal investigator for other novel agent trials. Dr Nicum is a committee member of the UK National Cancer Research Institute Gynaecological Oncology and the Ovarian Cancer Clinical Studies Groups.

 

 


Diseases, Medical Tests and Treatments
  • Chemotherapy
  • Immunotherapy
  • Ovarian Cancer
  • Gynaecological Cancers
Read more
Oncology
29 years of experience
Breast Cancer, Clinical Oncology

Dr Wolstenholme works as a Consultant Clinical Oncologist at Barts Health, London's largest NHS Trust. She completed her training at Guys and St Thomas' Hospital and at the Royal Marsden.

She is strongly committed to high quality, individualised cancer care and works closely with a specialist team of colleagues. Her special interests include developing new breast radiotherapy techniques and late effects of cancer treatment.


Diseases, Medical Tests and Treatments
  • Breast Cancer
  • Stereotactic Radiotherapy
  • Heart Sparing Radiotherapy
  • Breast Cancer
  • Stereotactic Radiotherapy
  • Heart Sparing Radiotherapy
Read more
Oncology
Clinical Oncology, Lung Cancer

Dr Hiley is an Associate Professor with tenure in Radiation Oncology at UCL and a Consultant Clinical Oncologist at UCLH.

He graduated with honours from the University in Manchester in 2005. He has trained in Oncology at many centres of excellence both in the UK and abroad. These include the Christie Hospital, the MD Anderson Cancer Centre (Houston, USA), Kings College (NIHR Clinical Lecturer) and the Royal Marsden (NIHR Clinical Fellow). He completed a PhD at the University of London with the Barts Cancer Institute and a postdoctoral research Fellowship at the Francis Crick Institute and the UCL Cancer Institute.

He became a consultant in 2018 and is clinical lead of the clinical oncology lung team at UCLH, UCLH Lead for Lung Proton Therapy, Deputy Lead of Clinical Trials for the CRUK Lung Cancer Centre of Excellence and NIHR Clinical Research Network Speciality Research Lead Radiotherapy for North London. He heads a research group at the UCL Cancer Institute focused on understanding resistance to radiation therapy.

Dr Hiley specialises in all the non-surgical treatments for all types of lung cancer. He has expertise in chemotherapy, immunotherapy and radiotherapy including state of the art radiotherapy techniques including Volumetric Arc Therapy (VMAT), Intensity Modulated Radiotherapy (IMRT), Image Guided Radiotherapy (IGRT), Proton Therapy and Stereotactic Radiotherapy (SBRT).

He is the principal investigator and national chief investigator for a number of academic and commercial clinical trials in lung cancer. He has published in a number of the world’s leading journals including NEJM, The Lancet, Nature and Cell. He is a member of the expert group which authored the Radiotherapy for Lung Cancer Royal College of Radiologists Consensus Statement.

Read more
Dr Fharat Raja

Dr Fharat Raja

1.27 miles

Dr Fharat Raja

1.27 miles
Oncology
22 years of experience
Breast Cancer, Medical Oncology